Chobani, Inc. — Plain Oat Drink, Plain
by Chobani, Inc.MRT 176 Panel Triggers Identified
Clinical Product Assessment
Chobani, Inc. manufactures this product, which has been analyzed against the full MRT 176 panel — comprising 149 foods and 27 chemical additives — to identify potential immune-mediated sensitivities.
MRT Safety Assessment
This product contains two MRT-tested substances (Oat and Canola/Rapeseed) and an undefined nutrient extract blend derived from various fruit and vegetable sources. Because the specific sources of the nutrient extract are not disclosed, they represent unknown variables that could contain additional MRT triggers. This product is not suitable for Phase 1 and requires practitioner guidance or individual testing for Phase 2.
Risk Summary
- Risk Classification: Requires Testing
- MRT Triggers Identified: 2
- Safe Ingredients: 6
- Unknown/Ambiguous: 1 (nutrient extract blend (fruit and vegetable sources))
- LEAP Phase Compatibility: Phase 2 — Reintroduction
Flagged Ingredient Mapping
The following ingredients were identified as matching substances on the MRT 176 panel:
| Ingredient | Maps To (MRT Panel) | Match Type |
|---|---|---|
| whole grain oats | Oat | Direct Match |
| canola oil | Canola/Rapeseed | Direct Match |
Unknown / Ambiguous Ingredients
The following ingredients could not be definitively mapped to the MRT 176 panel: nutrient extract blend (fruit and vegetable sources). Patients should treat these as potential triggers until MRT testing confirms safety.
LEAP Protocol Guidance
This product contains ingredients that could not be fully mapped to the MRT 176 panel. A Certified LEAP Therapist should review the ingredient list against the patient’s individual MRT results.
UPC Code: 818290016980
Assessment Methodology
This assessment was generated using Wellbloom’s automated clinical analysis pipeline. Each ingredient was cross-referenced against the complete MRT 176 panel — including 149 food antigens and 27 chemical additives.
This is procedural data interpretation, not medical guidance. Always consult your Certified LEAP Therapist.
Understanding These Triggers
Oat is independently tested on the MRT panel. Found in oatmeal, granola, and many "gluten-free" products that use oat flour. Distinct from wheat sensitivity.
Canola oil (derived from rapeseed) is an MRT-tested substance. It is one of the most common cooking oils in processed foods and restaurant cooking. Look for it in fried foods, dressings, and baked goods.
What This Means For Your Diet
With 2 identified triggers, this product falls into the moderate risk category. It may be suitable for Phase 2 reintroduction under practitioner guidance, depending on your individual MRT results.
If the specific triggers identified in this product scored Green on your personal MRT panel, your CLT may approve it for controlled reintroduction. If they scored Yellow or Red, this product should be avoided until cleared.
More from Chobani, Inc.
Chobani, Inc. — Original Plant-based Oatmilk, Original
Moderate RiskChobani, Inc. — WHOLE MILK GREEK YOGURT
High RiskChobani, Inc. — PINA COLADA PINEAPPLE COCONUT LOW-FAT GREEK YOGURT DRINK, PINA COLADA PINEAPPLE COCONUT
High RiskChobani, Inc. — WILD BLUEBERRY LESS SUGAR LOW-FAT GREEK YOGURT, WILD BLUEBERRY
About This Assessment
This safety assessment was generated by cross-referencing the USDA FoodData Central ingredient record for this product against the 176 substances tested on the Mediator Release Test (MRT) panel. Clinical notes are produced with AI assistance using the matched ingredient data and reviewed by Kerry Watson, NTP, RWP for accuracy against published LEAP ImmunoCalm® protocol guidelines. Risk classifications are based on the number and type of MRT-tested substances identified. This information is for educational purposes only and is not medical advice — always consult your Certified LEAP Therapist before making dietary changes.
Find a LEAP Therapist
Get personalized guidance from a Certified LEAP Therapist in your area.
Browse Practitioners